Inhibrx Biosciences, Inc. logo

Inhibrx Biosciences, Inc.

Innovation Focused Outcomes Driven

111 employees · est. 2010 · San Diego, United States

VS
Rubedo Life Sciences logo

Rubedo Life Sciences

Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging

32 employees · est. 2018 · Sunnyvale, United States

Inhibrx Biosciences, Inc. is the older company (2010 vs 2018); Inhibrx Biosciences, Inc. is the larger of the two.

Side-by-Side Comparison

Inhibrx Biosciences, Inc. Rubedo Life Sciences
Founded
2010 older 2018
Headquarters
San Diego, United States Sunnyvale, United States
Employees
111 larger 32
Industry
Biotechnology, Health and Wellness, Life Sciences Biotechnology, Health Care, Life Sciences
Funding Stage
Post Ipo Equity Series A
Total Funding
$269.59M $53.45M
Funding Rounds
5 7
Services
Not tracked yet Drug discovery and development, Clinical trials for anti-aging and chronic disease therapies, Research in biology of aging
Target Customers
Not tracked yet Patients with chronic diseases, Individuals seeking longevity and anti-aging solutions, Healthcare providers, Scientific researchers
Taxonomy
Biologic Therapeutics, Single Domain Antibodies, Cancer Treatment, Orphan Diseases, Clinical-stage Biotechnology, Oncology, Infectious Diseases, Protein Engineering, Target Biology, Multispecific Therapeutic Formats, Collaborations, NIH, NIAID, CARB-X Biopharmaceutical, Drug Discovery, Senescent Cells, Chronic Diseases, Innovative Therapies, Small Molecules, Pulmonary Diseases, Dermatological Diseases, Oncological Diseases, Neurodegenerative Diseases, Fibrotic Diseases, Biotech Innovators, Sunnyvale, California, Drug Development
Website
Inhibrx.com rubedolife.com
Inhibrx Biosciences, Inc. logo

About Inhibrx Biosciences, Inc.

Inhibrx, Inc. is a biotechnology startup founded in 2010 with a mission to provide optimized, biologic therapeutics for individuals facing life-threatening conditions. The company's diverse pipeline, based on single domain antibody platform technology, shows potential in addressing cancer and orphan...

Rubedo Life Sciences logo

About Rubedo Life Sciences

Rubedo Life Sciences, founded in 2018, is a promising player in the biotechnology, healthcare, and life sciences sectors. Headquartered in Sunnyvale, CA, this biopharmaceutical company is heralding a new era in age-related disease treatment with its pioneering approach. The company is known for its...

We will tell you when either one moves

BounceWatch watches Inhibrx Biosciences, Inc. and Rubedo Life Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Inhibrx Biosciences, I... and Rubedo Life Sciences — by email.

Frequently Asked Questions

Inhibrx Biosciences, Inc. — Innovation Focused Outcomes Driven. Rubedo Life Sciences — Medicines to keep you biologically young by targeting the pathological cells that drive chronic diseases of aging. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Inhibrx Biosciences, Inc. has raised $269.59M while Rubedo Life Sciences has raised $53.45M.
Inhibrx Biosciences, Inc. and Rubedo Life Sciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Inhibrx Biosciences, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Inhibrx Biosciences, Inc. on 9 Jun 2026, and Rubedo Life Sciences on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes